My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BioNTech SE - American Depositary Shares (NQ:BNTX)

100.22 +0.38 (+0.38%)

Streaming Delayed Price Updated: 9:34 AM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

71 72 Next >

Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today? ↗

December 19, 2023

A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) related to seeking fair compensation for infringement of a portfolio of

Via Benzinga

Topics Intellectual Property Lawsuit

BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda

December 18, 2023

From BioNTech SE

Via GlobeNewswire

3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024 ↗

December 18, 2023

Analysts think these beaten-down stocks could rebound strongly in the new year.

Via The Motley Fool

What's Going On With BioNTech (BNTX) Shares? ↗

December 13, 2023

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading lower by 5.6% to $93.10 Wednesday afternoon.

Via Benzinga

6 Analysts Have This to Say About BioNTech ↗

December 01, 2023

Via Benzinga

Analyst Ratings for BioNTech ↗

November 14, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday ↗

December 13, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Shares of Pfizer Inc. (NYSE: PFE) shares fell sharply during Wednesday’s session after the company...

Via Benzinga

Topics Stocks

Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints ↗

December 13, 2023

Pfizer's updated 2024 revenue figures, including Seagen, undercut the consensus target.

Via Investor's Business Daily

What's Going On With Moderna Stock Today? ↗

December 12, 2023

Moderna Inc (NASDAQ: MRNA) announced changes to its operating model to bring focus to its short- and

Via Benzinga

BioNTech to Inaugurate First African Site on December 18, 2023

December 12, 2023

From BioNTech SE

Via GlobeNewswire

BioNTech Stock Downgraded, Analyst Reflects Concerns Over Growth and Pipeline Development ↗

December 01, 2023

J.P.

Via Benzinga

Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 01, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

December 01, 2023

U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 points on Friday.

Via Benzinga

Topics Stocks

Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today? ↗

November 21, 2023

Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) /

Via Benzinga

Topics Intellectual Property

Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology ↗

November 15, 2023

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to...

Via Benzinga

Topics Intellectual Property Lawsuit

3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023 ↗

November 14, 2023

The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.

Via InvestorPlace

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 14, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal ↗

November 11, 2023

Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million...

Via Talk Markets

Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review ↗

November 10, 2023

The major indexes ended long win streaks. Datadog led earnings winners.

Via Investor's Business Daily

7 Underappreciated Biotech Stocks to Pick Up on the Cheap ↗

November 09, 2023

With questions rising about the economy, investors may consider undervalued biotech stocks for their relative insulation factor.

Via InvestorPlace

Topics Economy

Mohamed El-Erian On Yield And Oil Price Drop: Economic Boon Or Major Downturn Ahead? ↗

November 07, 2023

Via Benzinga

BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript ↗

November 06, 2023

BNTX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday ↗

November 06, 2023

Eli Lilly jumped, while energy plays were big winners and losers.

Via Investor's Business Daily

Topics Stocks

BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside. ↗

November 06, 2023

The company was expected to report a third-quarter loss and plummeting sales.

Via Investor's Business Daily

Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook ↗

November 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also...

Via Benzinga

Topics Stocks

Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades ↗

November 06, 2023

BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago.

Via Benzinga

US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields ↗

November 06, 2023

The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space.

Via Benzinga

Topics Economy

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

November 06, 2023

From BioNTech SE

Via GlobeNewswire

Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares ↗

November 02, 2023

The company issued below-consensus sales views for 2023 and 2024.

Via Investor's Business Daily

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

71 72 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.